Pacira Biosciences, Inc. (PCRX) SEC Filings — 2025
17 SEC filings for Pacira Biosciences, Inc. (PCRX) in 2025.
Filings
- Pacira Swings to Profit on Strong Sales, Reduced Impairments — 10-Q · Nov 6, 2025
- Pacira BioSciences Files 8-K on Financials — 8-K · Aug 5, 2025
- Pacira BioSciences Files 8-K on Exit Costs — 8-K · Jul 10, 2025
- Pacira BioSciences Enters New Agreements, Terminates Others — 8-K · Jul 7, 2025
- Pacira BioSciences Reports Director/Officer Changes & More — 8-K · Jun 13, 2025
- Pacira BioSciences Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Pacira Biosciences, Inc. DEF 14A Filing — DEF 14A · Apr 29, 2025
- Pacira BioSciences Acquires Pain Management Assets — 8-K · Apr 22, 2025
- Pacira BioSciences Files Proxy Statement — DEFA14A · Apr 18, 2025
- Pacira BioSciences Files Proxy Statement — DEFA14A · Apr 17, 2025
- Pacira BioSciences Files 8-K: Material Agreement & Financials — 8-K · Apr 7, 2025
- Pacira BioSciences Files 8-K for Bylaws and Exhibits — 8-K · Mar 14, 2025
- Pacira BioSciences Files Proxy Statement — DEFA14A · Mar 14, 2025
- Pacira BioSciences Files 8-K on Financials — 8-K · Feb 27, 2025
- Pacira BioSciences Appoints New CEO, David Stack — 8-K · Jan 30, 2025
- Pacira BioSciences Announces CFO Departure, New CFO & Directors — 8-K · Jan 21, 2025
- Pacira BioSciences Files 8-K on Financials — 8-K · Jan 10, 2025